- Home
- NXGL vs EVGN Comparison
NXGL vs EVGN Comparison
Compare NXGL & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXGL | EVGN |
|---|---|---|
| Founded | 1997 | 1999 |
| Country | United States | Israel |
| Employees | 19 | 52 |
| Industry | Medical/Dental Instruments | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9M | 5.3M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | NXGL | EVGN |
|---|---|---|
| Price | $0.56 | $0.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.00 | ★ $3.50 |
| AVG Volume (30 Days) | 309.4K | ★ 467.2K |
| Earning Date | 05-11-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $50.77 | N/A |
| Revenue Next Year | $46.15 | $73.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.48 | $0.37 |
| 52 Week High | $2.89 | $1.50 |
Technical Indicators
Market Signals| Indicator | NXGL | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 50.04 | 28.23 |
| Support Level | $0.48 | N/A |
| Resistance Level | $0.65 | $0.86 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 39.62 | 26.09 |
Price Performance
Historical ComparisonAbout NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.